Communicative Interaction for ALS
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how different communication methods might assist people with amyotrophic lateral sclerosis (ALS) and their caregivers. Specifically, it examines how structured and unstructured interactions impact verbal communication and whether these effects change over time. Participants will read words and sentences while interacting with their caregivers. Individuals with ALS who have noticeable speech difficulties and can speak single words may be suitable candidates. Their caregivers must also speak American English. As an unphased trial, this study provides participants the chance to contribute to significant research that could enhance communication strategies for ALS patients and their caregivers.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What prior data suggests that communicative interaction is safe for people with ALS and their caregivers?
Research has shown that communication methods like Clear Speech and Communicative Interaction are safe for people with ALS. These methods help improve communication skills, and past studies have found no harmful effects. Participants have generally handled these techniques well, with no major negative effects reported. This suggests that talking with caregivers, whether in a structured or casual way, is safe for individuals with ALS.12345
Why are researchers excited about this trial?
Researchers are excited about this trial because it focuses on enhancing communication for people with ALS, a condition where communication can become challenging due to muscle weakness. Unlike traditional treatments that often aim to slow disease progression or manage symptoms with medication, this trial explores "Structured Communicative Interaction" as a way to improve the quality of life by fostering better communication between patients and their caregivers. This approach is unique because it emphasizes behavioral and social interaction techniques rather than relying solely on medical or technological interventions. By focusing on structured communication, the trial may pave the way for more effective support systems that significantly enhance daily interactions for those affected by ALS.
What evidence suggests that structured communicative interaction is effective for improving verbal communication in people with ALS?
Studies have shown that most people with ALS struggle to communicate, and up to 95% may eventually lose their ability to speak. Caregivers can assist by adjusting how they listen and respond, which can improve communication for ALS patients. Research indicates that these methods help caregivers understand the unique ways ALS patients speak. This can enhance verbal communication between patients and caregivers, helping them maintain meaningful interactions. Participants in this trial will engage in structured communicative interaction to explore these benefits further.13678
Who Is on the Research Team?
Jimin Lee, Ph.D.
Principal Investigator
Penn State University
Anne Olmstead, Ph.D.
Principal Investigator
Penn State University
Navin Viswanathan, Ph.D.
Principal Investigator
Penn State University
Are You a Good Fit for This Trial?
This trial is for individuals with ALS (Lou Gehrig's disease) and their caregivers. It aims to understand how structured and unstructured communication affects verbal interaction over time. Participants will engage in reading tasks with their caregivers.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Pre-test
Participants engage in initial interactive tasks to assess baseline speech characteristics
Intervention
Participants complete collaborative word-matching tasks with caregivers using tablets and audio recording devices
Post-test
Participants engage in follow-up interactive tasks to assess changes in speech characteristics
Follow-up
Participants are monitored for any long-term changes in speech and communication effectiveness
What Are the Treatments Tested in This Trial?
Interventions
- Structured Communicative Interaction
- Unstructured Communicative Interaction
Find a Clinic Near You
Who Is Running the Clinical Trial?
Penn State University
Lead Sponsor
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator